LFWD vs. RBOT, MLSS, NTRB, COCH, CLGN, CTSO, INAB, LNSR, NHIQ, and OKYO
Should you be buying ReWalk Robotics stock or one of its competitors? The main competitors of ReWalk Robotics include Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Nutriband (NTRB), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Cytosorbents (CTSO), IN8bio (INAB), LENSAR (LNSR), NantHealth (NHIQ), and OKYO Pharma (OKYO). These companies are all part of the "medical" sector.
Vicarious Surgical (NYSE:RBOT) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings, valuation and community ranking.
Vicarious Surgical currently has a consensus price target of $0.67, indicating a potential upside of 113.68%. ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 78.22%. Given ReWalk Robotics' higher possible upside, research analysts clearly believe Vicarious Surgical is more favorable than ReWalk Robotics.
Vicarious Surgical received 6 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
Vicarious Surgical has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 2.06, suggesting that its stock price is 106% more volatile than the S&P 500.
Vicarious Surgical has a net margin of 0.00% compared to Vicarious Surgical's net margin of -159.76%. Vicarious Surgical's return on equity of -28.19% beat ReWalk Robotics' return on equity.
In the previous week, ReWalk Robotics had 7 more articles in the media than Vicarious Surgical. MarketBeat recorded 7 mentions for ReWalk Robotics and 0 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 0.16 beat ReWalk Robotics' score of 0.00 indicating that ReWalk Robotics is being referred to more favorably in the news media.
47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are owned by institutional investors. 11.7% of Vicarious Surgical shares are owned by company insiders. Comparatively, 2.1% of ReWalk Robotics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
ReWalk Robotics has higher revenue and earnings than Vicarious Surgical. ReWalk Robotics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
ReWalk Robotics beats Vicarious Surgical on 10 of the 17 factors compared between the two stocks.
Get ReWalk Robotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ReWalk Robotics Competitors List
Related Companies and Tools
